Our leaders, researchers, and physicians are shaping the future of oncology through groundbreaking discoveries and transformative contributions. These are some of the highlights of prestigious national awards and appointments.
Karen Huntsman helped build a movement against cancer—one defined by compassion, vision, and hope. Her legacy will continue to shape care, research, and the lives of patients and families.
In Southeast Idaho, a new affiliation brings advanced clinical expertise, research, and treatment options closer to home for these patients and families.
A clinical trial led by Neeraj Agarwal, MD, FASCO, found that a combination prostate cancer therapy could slow disease progression for patients with certain gene alterations, including BRCA.
From the seat of an excavator, cancer survivor Noah Reeb officially broke ground on an expansion that will double capacity, bring lifesaving care closer to home, and advance research, education...
What if cancer cells are using a signaling shortcut we’ve been missing? Scientists uncovered a mechanism in a key cell-to-cell communication system—insight that could point to more effective therapies.
Utah’s $33 million investment fuels AI, advanced computing, and secure data innovation—strengthening health research and discovery statewide through leadership at the University of Utah and Huntsman Cancer Institute.
The first three patients have been treated in an early-stage clinical trial of a new radiopharmaceutical medicine at Huntsman Cancer Institute, marking an important step in developing new cancer therapies.
Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children with T-ALL, potentially enabling clinicians to make faster, personalized treatment decisions.
A Huntsman Cancer Institute researcher evaluated a noninvasive skin imaging technology that accurately discriminates between common moles and melanoma, potentially enhancing melanoma screening while reducing the need for unnecessary biopsies.
Advancing detection of prostate cancer, a new imaging drug targets PSMA—a protein marking cancer cells—helping physicians identify disease earlier and guiding patients toward timely, confident treatment decisions.
A breakthrough clinical trial for a deadly brain tumor, how fatty acids affect breast cancer risk, upending our ideas about melanoma’s origins, and a new drug for sarcoma patients.
Leaders at Huntsman Cancer Institute are shaping the future of oncology through groundbreaking research, influential roles, and transformative contributions recognized by prestigious national awards and appointments.
The STELLAR research trial found that a new combination therapy improved survival rates for patients with grade 3 astrocytoma, an aggressive form of brain cancer.
Huntsman Cancer Institute opens the Mountain West’s first combined angio-CT suite, enhancing cancer care with same-day imaging, improved outcomes, and reduced travel for patients needing complex interventional treatments.
The addition of our da Vinci 5 systems enhances surgery precision, decreases recovery times, and improves access for patients. This strengthens our role as a leader in robotic surgical care.
Recent national rankings highlighted strong clinical outcomes, specialized treatment, research leadership, and patient-centered care, securing Huntsman Cancer Institute’s position among the top cancer centers in the United States.
Researchers at Huntsman Cancer Institute found that lipids fuel growth in triple-negative breast cancer cells. High-fat diets like keto could unintentionally worsen outcomes for breast cancer patients with obesity.
Neli Ulrich, PhD, MS, has been elected vice president/president-elect of the American Association of Cancer Institutes, honoring her impactful leadership in cancer research and advocacy for collaborative discovery and innovation.
A grant to study endometrial cancer and progestins, a review of gaps in skin cancer care, an immunotherapy system for multiple myeloma patients, and how cell identity affects tumor growth.
Researchers found people with multiple tattoo sessions have a lower risk of melanoma. Experts stress more research is needed to confirm these unexpected findings, and to investigate potential mechanisms.
Proposed $50 million, 5-year deal with HPE would enlarge the U's computing power 3.5-fold using NVIDIA chips, driving new discoveries and innovation in cancer care and beyond.
Bradley Cairns, PhD, takes the helm as CEO of Huntsman Cancer Institute, continuing the legacy of excellence in cancer research, care, and community impact.
Huntsman Cancer Institute has appointed experienced leaders to guide its growing research and clinical program in theranostics, a promising new way to find and treat cancer.
The Senator Orrin G. Hatch Proton Therapy Center, the first and only in the region, is expanding. The project will double patient capacity and enhance access to innovative radiation treatment.
Huntsman Cancer Institute, alongside the Price College of Engineering and other departments at the University of Utah, awarded grants to interdisciplinary research teams seeking innovative engineering solutions for cancer challenges.
After 20 years of transformative leadership, Mary Beckerle steps down as CEO and Brad Cairns is named successor to continue advancing cancer research and care across the Mountain West.
Three new physician-scientists have been welcomed to The Society of Huntsman Translational Scholars, recognizing their groundbreaking work in translating cancer research into real-world innovations that improve patient care.
